A detailed history of Hsbc Holdings PLC transactions in Surmodics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 247,535 shares of SRDX stock, worth $9.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
247,535
Holding current value
$9.84 Million
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$38.47 - $42.24 $9.52 Million - $10.5 Million
247,535 New
247,535 $9.6 Million
Q2 2022

Aug 11, 2022

SELL
$33.25 - $45.11 $165,651 - $224,738
-4,982 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$40.68 - $49.72 $202,667 - $247,705
4,982 New
4,982 $225,000
Q4 2018

Feb 13, 2019

SELL
$44.93 - $73.38 $367,482 - $600,175
-8,179 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$56.85 - $80.35 $464,976 - $657,182
8,179 New
8,179 $610,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $557M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.